✦ LIBER ✦

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

✍ Scribed by Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi

Publisher: Springer
Year: 2009
Tongue: English
Weight: 509 KB
Volume: 14
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-009-0935-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ovarian cancer in endometriosis: epidemi

Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis

✍ Hiroshi Kobayashi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 216 KB

The prognostic value of clinical, pathol

The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer

✍ Soo Keat Khoo; Diana Battistutta; Terence Hurst; Barbara Sanderson; Bruce G Ward 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

## Background: The prognosis in ovarian cancer remains poor, and there is a need to identify patients who are less likely to respond to treatment. ## Methods: In a study of 133 unselected patients with ovarian adenocarcinoma treated by a standard protocol, variables such as age, tumor type, inter

Molecular biology of dissemination in bl

Molecular biology of dissemination in bladder cancer — laboratory findings and clinical significance

✍ B. J. Schmitz-Dräger; F. Jankevicius; R. Ackermann 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 898 KB

Anaplastic transformation of thyroid can

Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy

✍ Sam M. Wiseman; Thom R. Loree; Nestor R. Rigual; Wesley L. Hicks Jr.; Wade G. Do 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Background: Anaplastic thyroid cancer ranks among the most lethal of all human malignancies. its rarity and rapidly fatal course have made it a difficult cancer to both study and treat. unfortunately, there has been little progress in the management and control of this malignancy. anaplastic tra

Molecular profiling of platinum resistan

Molecular profiling of platinum resistant ovarian cancer: Use of the model in clinical practice

✍ Olivier Gevaert; Nathalie Pochet; Frank De Smet; Toon Van Gorp; Bart De Moor; Di 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 39 KB

With great interest we read the article by Helleman et al., 1 investigating whether a gene set identified using microarrays could be used to predict platin resistance in ovarian cancer. The authors studied a training set obtained from 24 tumours that were analysed using cDNA microarrays. This set co

Clinical impact of molecular genetic dia

Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer : Part I: Studies of cancer in families

✍ Henry T. Lynch; Patrice Watson; Trudy G. Shaw; Jane F. Lynch; Anne E. Harty; Bar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 3 views

Hereditary cancer represents approximately 5-10% of the total cancer burden and may account for 60,000 to 120,000 new cancer occurrences this year in the United States. New developments in molecular genetics and the cloning of cancer-prone genes have intensely fueled interest in dealing with heredit